The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2005-09-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta9340 |
_version_ | 1811231108528865280 |
---|---|
author | D Symmons K Tricker C Roberts L Davies P Dawes D Scott |
author_facet | D Symmons K Tricker C Roberts L Davies P Dawes D Scott |
author_sort | D Symmons |
collection | DOAJ |
first_indexed | 2024-04-12T10:39:47Z |
format | Article |
id | doaj.art-be430fca359f4b989b8b01cefc0601a0 |
institution | Directory Open Access Journal |
issn | 1366-5278 |
language | English |
last_indexed | 2024-04-12T10:39:47Z |
publishDate | 2005-09-01 |
publisher | NIHR Journals Library |
record_format | Article |
series | Health Technology Assessment |
spelling | doaj.art-be430fca359f4b989b8b01cefc0601a02022-12-22T03:36:38ZengNIHR Journals LibraryHealth Technology Assessment1366-52782005-09-0193410.3310/hta9340The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritisD Symmons0K TrickerC RobertsL DaviesP DawesD ScottARC Epidemiology Unit, University of Manchester, UKhttps://doi.org/10.3310/hta9340 |
spellingShingle | D Symmons K Tricker C Roberts L Davies P Dawes D Scott The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis Health Technology Assessment |
title | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
title_full | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
title_fullStr | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
title_full_unstemmed | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
title_short | The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
title_sort | british rheumatoid outcome study group brosg randomised controlled trial to compare the effectiveness and cost effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis |
url | https://doi.org/10.3310/hta9340 |
work_keys_str_mv | AT dsymmons thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT ktricker thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT croberts thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT ldavies thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT pdawes thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT dscott thebritishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT dsymmons britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT ktricker britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT croberts britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT ldavies britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT pdawes britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis AT dscott britishrheumatoidoutcomestudygroupbrosgrandomisedcontrolledtrialtocomparetheeffectivenessandcosteffectivenessofaggressiveversussymptomatictherapyinestablishedrheumatoidarthritis |